# Magnesium Taurate Cognition Randomized Trial: What the Evidence Says
Canonical: https://www.migaku.app/guides/magnesium-taurate-cognition-randomized-trial-evidence-review
Category: evidence-review
Summary: Magnesium Taurate Cognition Randomized Trial has 1 source documents in the current Migaku evidence database. The strongest available sources in this first pas
Last reviewed: 2026-07-10
Reviewed by: Migaku Evidence Review
# Magnesium Taurate Cognition Randomized Trial: What the Evidence Says

## Quick Answer

Magnesium Taurate Cognition Randomized Trial has 1 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomedical and public-health sources, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 research article.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Vitamin/mineral/micronutrient supplement for autism spectrum disorders: a research survey | research article | 4 | 2022-10-13 | 10.1186/s12887-022-03628-0 |

## What The Sources Report

- In the United States, data from the National Health and Nutrition Examination Survey (NHANES) 2007-2010 ( = 16,444) found that many people consume less than the estimated average requirement (EAR) of many nutrients, including vitamin D (74%), vitamin E (67%), magnesium (46%), calcium (39%), and vitamin A (35%). [Adams James B. (2022); evidence level 4]
- Children with ASD may have an increased need for vitamin/mineral supplementation, due to a variety of metabolic problems, including increased oxidative stress, methylation pathway insufficiency, mitochondrial disorders, cerebral folate transporter antibodies, sulfate deficiency and lithium deficiency. [Adams James B. (2022); evidence level 4]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

For magnesium taurate cognition randomized trial, the current source set is useful for orientation, but it is not yet broad enough for strong claims. Use cautious language and keep conclusions close to the cited sources.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Adams James B. (2022). Vitamin/mineral/micronutrient supplement for autism spectrum disorders: a research survey. DOI: 10.1186/s12887-022-03628-0. PMCID: PMC9558401. PMID: 36229781. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC9558401/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.